Cassava Sciences Files 8-K
Ticker: FLNA · Form: 8-K · Filed: May 1, 2024 · CIK: 1069530
| Field | Detail |
|---|---|
| Company | Cassava Sciences INC (FLNA) |
| Form Type | 8-K |
| Filed Date | May 1, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, regulatory
Related Tickers: SAVA
TL;DR
Cassava Sciences filed a routine 8-K, no major news here.
AI Summary
Cassava Sciences, Inc. filed an 8-K on May 1, 2024, to report other events and financial statements. The filing does not contain specific financial figures or details about the 'other events' in the provided text, but it confirms the company's reporting status.
Why It Matters
This filing indicates Cassava Sciences is fulfilling its regulatory reporting obligations with the SEC, which is standard for publicly traded companies.
Risk Assessment
Risk Level: low — This is a routine SEC filing with no new material information provided in the excerpt.
Key Players & Entities
- Cassava Sciences, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- Austin, Texas (location) — Principal Executive Offices
FAQ
What specific 'Other Events' are being reported by Cassava Sciences in this 8-K filing?
The provided text of the 8-K filing does not specify the details of the 'Other Events' being reported.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted on May 1, 2024.
What is the principal business address of Cassava Sciences, Inc.?
The principal executive offices are located at 6801 N Capital of Texas Highway, Building 1; Suite 300, Austin, Texas 78731.
What is Cassava Sciences' IRS Employer Identification Number?
Cassava Sciences' IRS Employer Identification Number is 91-1911336.
What is the SEC file number for Cassava Sciences?
The SEC file number for Cassava Sciences is 001-41905.
Filing Stats: 433 words · 2 min read · ~1 pages · Grade level 9.6 · Accepted 2024-05-01 09:13:13
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value SAVA NASDAQ Capital Market
Filing Documents
- f8k_050124.htm (8-K) — 14KB
- exh_991.htm (EX-99.1) — 11KB
- exh_992.htm (EX-99.2) — 11KB
- 0001171843-24-002403.txt ( ) — 239KB
- gnw-20190101.xsd (EX-101.SCH) — 3KB
- gnw-20190101_def.xml (EX-101.DEF) — 25KB
- gnw-20190101_lab.xml (EX-101.LAB) — 33KB
- gnw-20190101_pre.xml (EX-101.PRE) — 22KB
- f8k_050124_htm.xml (XML) — 3KB
01. Other Events
Item 8.01. Other Events. On May 1, 2024, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The Notice of Guaranteed Delivery is attached as Exhibit 99.2 and is incorporated herein by reference.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. 99.1 Press Release dated May 1, 2024 99.2 The Notice of Guaranteed Delivery 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Cassava Sciences, Inc. Date: May 1, 2024 By: /s/ Eric J. Schoen Eric J. Schoen Chief Financial Officer